ANIPANI Pharmaceuticals, Inc.

$2B

FY 2012 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2M+428.7% YoY

Gross Profit

-$7M-298.4% margin

Operating Income

-$23M-1007.1% margin

Net Income

-$28M-1204.7% margin

EPS (Diluted)

$-7.64

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$26M

Stock-Based Comp.

$725,625

Balance Sheet

Total Assets

$39M

Total Liabilities

$11M

Stockholders' Equity

$28M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$435,160	+428.7%
Gross Profit	-$7M	$385,160	-1882.7%
Operating Income	-$23M	-$51M	+54.5%
Net Income	-$28M	-$52M	+46.3%

ANIP FY 2012 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena